$ACI

Albertsons Beats Second-Quarter Earnings Estimates but Withdraws 2026 Guidance Amid Business Review

Albertsons (ACI) reported Q2 adjusted EPS of $0.36, beating estimates by $0.03, with revenue at $18.89B, flat YoY. However, comparable sales fell 0.8%, and profitability weakened, prompting the company to withdraw its 2026 guidance. The retailer announced a business review to cut costs and improve operations. Shares dropped 1.12% in pre-market trading.

Original reporting
Published Oct 13, 2026, 12:26 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 12:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Albertsons Beats Second-Quarter Earnings Estimates but Withdraws 2026 Guidance Amid Business Review — source image
Decision brief

The 30-second read

$ACIBearishMed
01

Why it matters

Guidance withdrawal introduces uncertainty, likely prompting short‑term downside while the earnings beat offers a modest positive offset.

02

Market read

Earnings beat combined with guidance removal creates mixed signals; traders should monitor cost‑review updates.

03

What to watch

Potential upside from digital sales momentum and pharmacy growth may offset margin pressure.

Relevance 8/10Novelty 8/10Timing: pre‑market today

Background

Albertsons reported Q2 FY2026 results, beat EPS expectations, but announced a comprehensive business review and withdrew its full‑year guidance.

Company-level read

Ticker impact

$ACIBearishMedium confidence
Context

Q2 earnings beat estimates but Albertsons withdrew FY2026 guidance, shares down 1.12% pre‑market.

Expected impact

likely pressure as market prices in the lack of guidance and cost‑structure concerns

Evidence & confidence

The company beat earnings but removed its full‑year outlook and announced a cost review, prompting a sell‑off.

Market effects

Signals pressure on the U.S. grocery sector as peers may face similar cost‑structure challenges.

May weigh on U.S. consumer‑discretionary sentiment in the short term.

Limited to U.S. retail investors; no immediate global ripple.

Counterpoint

The earnings beat and digital sales growth could support a rebound if the cost review yields clear savings.

Key entities

  • Albertsons Companies, Inc.

    U.S. grocery retailer (ticker ACI) reporting Q2 results and withdrawing guidance.

Related articles

$ACIMed

Transcript: Albertsons Companies Q2 2026 Earnings Conference Call - Albertsons Companies (NYSE:ACI)

Albertsons (NYSE:ACI) reported Q2 2026 identical sales down 0.8%, adjusted EBITDA $784M, and adjusted EPS $0.36. E-commerce sales grew 11%, while pharmacy sales remained strong. The company aims for $2B in cost savings over three years and is reviewing its business to enhance shareholder value. Albertsons generated $1.2B in operating cash flow and repurchased $400M in shares in the first half of 2026.

$ACIMedAI 8/10

Albertsons suspends fiscal 2026 guidance, launches business review Q2

Albertsons reported a 69% drop in Q2 net income to $51.5M, with sales down 0.1% to $18.89B. Adjusted EPS of $0.36 and revenue beat analyst estimates. The company suspended fiscal 2026 guidance and launched a business review to cut costs and improve strategy, targeting an investor day in spring 2027. Albertsons also declared a $0.17 quarterly dividend and repurchased 26M shares for $387.6M. The company is pursuing a $9.3B lawsuit against Kroger over a failed merger.

$ACIHigh

US grocer Albertsons pulls annual outlook, accelerates turnaround efforts

Albertsons withdrew its fiscal 2026 outlook and announced a business review to cut costs, lower prices, and boost sales. The grocer faces challenges from cautious consumer spending and market share losses. CEO Susan Morris and Executive Chair Meg Whitman aim to accelerate turnaround efforts. Shares rose 2% on Tuesday, despite a 27% decline year-to-date. Q2 adjusted profit beat estimates at $0.36 per share.